Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Acrivon Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $585.06 by 1 insider.
This reflects the filings imported so far, not a complete trading history.
Show all loaded activityNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.